Gene Query: SNRNP40

Dataset Description Geneva Score
IQGAP3 interacts with Rad17 to activate the MRN/ATM/Chk2 signaling and promote radioresistance in lung cancer 65.91
Suppression of ribosomal pausing by eIF5A is necessary to maintain the fidelity of start codon selection 25.36
Suppression of ribosomal pausing by eIF5A is necessary to maintain the fidelity of start codon selection (RNA-sequencing) 25.36
Development of a selective CDK9 degrader from a multi-targeted CDK inhibitor [RNA-seq] 25.17
Development of a selective CDK9 degrader from a multi-targeted CDK inhibitor 25.17
Gene expression analysis of the impact of TDP-43 knockout in human cells. 23.95
Identifying lincRNA as prognostic biomarker for clear cell renal cell carcinoma 23.79
ncRNA (non-coding RNA) signature in endothelial cells during hypoxia [RNA-seq] 21.92
ncRNA (non-coding RNA) signature in endothelial cells during hypoxia 21.92
Co-transcriptional loading of RNA export factors shapes the human transcriptome 19.9
RNAseq of HEK293 cells after Chtop knockdown 19.9
RNA expression analysis of neuroblastoma cell lines treated with epigenetic drugs 18.16
Lineage tracing of acute myeloid leukemia reveals the impact of hypomethylating agents on chemoresistance selection 16.75
Total RNA deep sequencing (ribosomal depleted) of human umbilical vein endothelial cells exposed to hypoxia (0.2%) for 12h and 24h or kept under normoxic conditions. 16.67
Endothelial gene expression analysis 16.67
Club cells surviving influenza A virus infection induce temporary non-specific anti-viral immunity 15.98
H3B-8800, a novel oral splicing modulator, induces lethality in spliceosome mutant cancers [Nalm-6] 15.87
LncRNA-GAS5 negative regulation of YAP-target genes expression 14.67
24hr CA treatment vs. DMSO in HCT116 cells (from 'Identification of CDK8 and CDK19 substrates in human cells using cortistatin A and quantitative phosphoproteomics') 14.21
RNA expression analysis upon JMJD1C depletion 14.06
JMJD1C is required for the survival of acute myeloid leukemia by functioning as a co-activator for key transcription factors 14.06
Isolation and Transcriptome Analyses of Human Erythroid Progenitors: BFU-E and CFU-E 13.61
Human CD4+CD103+ cutaneous resident memory T cells are found in the circulation of healthy subjects 13.5
Genomic basis for clinical response to histone deacetylase inhibition in advanced urothelial carcinoma 13.48
Integrated analyses of early responses to radiation in glioblastoma identify new alterations in RNA processing and candidate targets to improve treatment outcomes 13.31
INO80 governs super-enhancer-mediated oncogenic transcription and tumor growth in melanoma 13.2
INO80 governs super-enhancer-mediated oncogenic transcription and tumor growth in melanoma [RNA-seq] 13.2
Presence of NAD+-capped RNA in human cells: function and removal by the DXO deNADing Protein 12.96
ARID1A loss impairs enhancer-mediated gene regulation and drives colon cancer in mice [HCT116_RNA-seq] 12.96
ARID1A loss impairs enhancer-mediated gene regulation and drives colon cancer in mice 12.96
3’ Uridylation Expands miRNA Target Repertoire 12.9
The Developmental Heterogeneity of Human Natural Killer Cells Defined by Single-cell Transcriptome 12.88
Biased Expression of the FOXP3Δ3 Isoform in Aggressive Bladder Cancer Mediates Differentiation and Cisplatin Chemotherapy Resistance 12.87
Campylobacter concisus pathotypes induce distinct global responses in intestinal epithelial cells [BAA] 12.57
ChIP-seq and RNA-seq in BGC823 cells after downregulation of GAS1 expression 12.43
A novel lncRNA GAS1 promotes gastric carcinogenesis and acts as a modular scaffold of WDR5 and KAT2A complexes to specify the histone modification pattern [RNA-seq] 12.43
A Unique Epigenomic Landscape Defines Human Erythropoiesis (RNA-seq) 11.9
A Unique Epigenomic Landscape Defines Human Erythropoiesis 11.9
TRIM28 interacts with EZH2 and SWI/SNF to activate genes that promote mammosphere formation 11.86
Genome-wide CRISPR-Cas9 screen identifies functionally relevant microRNAs in AML 11.74
Expression profile of wild type (WT) vs miR-155-/- in FLT3-ITD+ AML (MV4-11) cell lines 11.74
LNCaP treated with iBET 11.61
Tracking distinct RNA populations using efficient and reversible covalent chemistry 11.41
Effect of CHKA knockdown on C4-2 cell transcriptome 11.34
Crizotinib v. DMSO in SW480 cells 11.21
SOX21 ensures rostral forebrain identity by suppression of WNT8B during neural regionalization of human embryonic stem cells 11.11
CD95L derived si- and shRNAs and the CD95L mRNA kill cancer cells through an RNAi mechanism by targeting survival genes [siL3.RNAseq.lg] 11.07
Che-1 is targeted by c-Myc to sustain proliferation in pre-B-cell acute lymphoblastic leukemia 11.04
Che-1 is targeted by c-Myc to sustain proliferation in pre-B-cell acute lymphoblastic leukemia [RNA-seq] 11.04
U1 snRNP telescripting regulates size-function stratified human genome 10.88
Identification of mRNAs with reduced ribosomal loading upon knock-down of translation factor DAP5 from hESCs. 10.77
Transcriptome sequencing of K-562 cells 10.74
ETS family proteins bind glucocorticoid receptor: relevance for treatment of Ewing sarcoma 10.68
RNA-seq of resting and activated CD4+ T cells +-JQ1 10.66
LINE-1 elements are derepressed in senescent cells and elicit a chronic Type-I Interferon response 10.65
RNAseq to determine whether bidirectional transcription occurs over transposable elements following depletion of SETDB1 in THP-1 AML Cells 10.53
Sequencing Universal Human Reference RNA by Smart-seq and early barcoding library preparation methods 10.42
RNA Sequencing Reveals Immunosuppressive Role of Anthrax Lethal Toxin in Human Lung Epithelial and Monocytic Cells 10.35
In vitro differentiation of human embryonic stem cells into ovarian follicle-like cells 10.31
CREB5 promotes resistance to androgen-receptor antagonists and androgen deprivation in prostate cancer 10.31
Enhancing human kidney organoid differentiation from pluripotent stem cells with high-throughput automation 10.23
Enriched EWSR1 and EWS-FLI1 RNA-seq of HNRNPH1-silenced TC32 Ewing sarcoma and 293T human embryonic kidney cells. 10.19
Assembly of methylated LSD1 and CHD1 drives AR-dependent transcription and translocation 10.16
Assembly of methylated LSD1 and CHD1 drives AR-dependent transcription and translocation [RNA-Seq] 10.16
SPOP mutation confers intrinsic BET inhibitor resistance in prostate cancer (BRD4_JQ1_RNA-seq) 10.12
Global transcriptional changes in the JJN3 myeloma cell line that occur as a result of treatment with 2 pyrrolobenzodiazepine (PBD) monomers 10.09
Transcriptome analysis of dominant-negative Brd4 mutants identifies Brd4-specific target genes of BET inhibitor JQ1 9.98
Biosynthesis of histone messenger RNA employs a specific 3' end endonuclease 9.95
Transcriptomes analysis for the regulation of Z36 induced autophagy in HeLa cell death 9.85
Global analysis of pre-mRNA subcellular localization upon splicing inhibition by spliceostatin A 9.82
Genistein and bisphenol A exposure cause estrogen receptor 1 to bind thousands of binding sites in a cell type-specific manner 9.72
The role of PHF19 in promoting H3K27me3 deposition in multiple myeloma 9.7
The role of PHF19 in promoting H3K27me3 deposition in multiple myeloma (RNA-Seq) 9.7
Total RNA-seq in ALL-SIL upon JQ1 inhibition 9.69
Genome-wide transcriptome analysis of NIPBL iPSC and commited cardiomyoctes 9.64
RNAseq to determine gene expression changes following depletion of SETDB1 in THP-1 AML Cells 9.54
H3K27ac ChIP-Seq and mRNA-Seq analysis of five human B-lymphoblastoid cell lines (LCLs) prepared from the same healthy male individual (CEPH/UTAH). 9.34
The impact of stanniocalcin 1 on the transcriptome of human cord blood stem/progenitors 9.29
Splicing towards noncoding isoforms in colorectal carcinoma is associated with tumor hypoxia and the DNA damage response 9.28
Polysome-associated mRNA profiling of cancer cells in response to CXCL12 and IGF1 9.26
Role of XRN2 ribonucleolytic activity in RNA metabolism 9.24
A role for p53 in the adaptation to glutamine starvation through the expression of Slc1a3 9.21
Transcription control by the ENL YEATS domain in acute leukemia 9.14
Transcription control by the ENL YEATS domain in acute leukemia [RNA-seq] 9.14
circ-ZNF609 regulates G1-S progression in Rhabdomyosarcoma 9.05
Regulation of protein translation during mitosis 9.03
Gene expression profile of LMSU gastric cancer cell p53 KO and KD 8.96
RNA-sequencing of isogenic primary, pre-malignant immortalized, and Ras-transformed human mammary epithelial cells 8.91
Characterization of human CDK12 and CDK13 in the regulation of RNA processing 8.86
Bromodomain protein BRD4 is a transcriptional repressor of autophagy and lysosomal function 8.85
MenSCs inhibit HCC growth through oncogenic pathway suppression via regulating 5-hmC in enhancer elements [RNA-seq] 8.79
MenSCs inhibit HCC growth through oncogenic pathway suppression via regulating 5-hmC in enhancer elements 8.79
RNA-Seq analysis of 4N and 2N RPE1 cells following polyploid induction via cytokinesis failure or Aurora kinase inhibition [tpo3] 8.79
RNA-seq of IL-4 stimulated human keratinocytes 8.78
Selective expansion of myeloid and NK cells in humanized mice yields human-like vaccine responses (Experiment 1: RNA-seq) 8.77
Circular RNAs are down-regulated in KRAS mutant colon cancer cells and can be transferred to exosomes 8.67
TT-Seq captures the human transient transcriptome 8.66
Ribosomal footprinting of CN34-Parental and CN34-LM1a 8.64
Widespread N6-methyladenosine-dependent RNA Structural Switches Regulate RNA-Protein Interactions 8.63
Transriptional profiling upon heat shock and recovery in cells deficient for FBXW7 and their wild type counterpart. 8.53
FBXW7 modulates stress response by post-translational modification of HSF1 8.53
Gene expression profiling associated with knockdown of LKB1 in human intrahepatic cholangiocarcinoma 8.53
Ribosomal footprinting of MDA-Parental and MDA-LM2 8.53
Trans-differentiation of human adult peripheral blood T cells into neurons 8.5
RNA-seq after siRNA targeting DDX24 applied to iHUVECs cell lines 8.48
Comparative transcriptomic analysis of human and Drosophila extracellular vesicles reveals extensive conservation 8.46
Comprehensive comparative analysis of 5’ end RNA sequencing methods 8.46
Identification of transcription start sites for human A549 cell line using ReCappable-seq 8.41
Lyophilized human cells stored at room temperature preserve multiple RNA species at excellent quality for RNA sequencing 8.37
The RNA hairpin binder TRIM71 modulates alternative splicing by repressing MBNL1 8.36
The RNA hairpin binder TRIM71 modulates alternative splicing by repressing Mbnl1 [RNA-seq & Ribo-seq] 8.36
The LIN28B/let-7 axis is a novel therapeutic pathway in Multiple Myeloma 8.32
Epigenetic siRNA and chemical screens identify SETD8 inhibition as a new therapeutic strategy of p53 reactivation in high-risk Neuroblastoma. 8.32
Hit-and-run' programing of CAR-T cells using mRNA nanocarriers 8.29
Transcriptome of iPSC-derived Neural Cells with Heterozygous Knockout in CHD8 8.27
scRNASeq analysis of cycling cardiomyocytes 8.25
Stem and effector CD8 T-cells from human cancers 8.18
RNA-seq analysis of differentiating human erythroblasts 8.17
Global Transcriptome Analyses of Mammalian Terminal Erythroid Differentiation 8.16
The landscape of alternative splicing in aggressive prostate cancers 8.16
Transcriptome analysis of H9 hESC derived cerebral organoids 8.15
Single-cell RNA sequencing-based CRISPRi screening resolves molecular drivers of early human endoderm development [set 1] 8.02
NR4A1 Inhibition Synergizes with Ibrutinib in Killing Mantle Cell Lymphoma Cells 8.01
Whole Transcriptome RNASeq Data for Cell-Sorted Antibody Secreting Cells (ASC) 8.0
Biological effect of chronic mistranslation in mammalian cells 7.98
Seletive inhibition of CDK9 in DLBCL cell lines 7.98
Biochemical fractionation of HEK293 nuclei and RNA-seq of chromatin-associated and soluble-nuclear RNA 7.93
Transcriptome analysis of immature and matured human oocytes from patients of young and advanced maternal age 7.91
Vitamin C Promotes Apoptosis in Breast Cancer Cells by Increasing TRAIL Expression 7.9
RNA-seq transcriptonal profiling in human primary adult erythroid progenitor cells (ProEs) after shRNA-mediated depletion of TFAM and PHB2 expression 7.89
Axitinib exposure triggers endothelial cells senescence through ROS accumulation and ATM activation 7.89
Aging Human Hematopoietic Stem Cells Manifest Profound Epigenetic Reprogramming of Enhancers That May Predispose to Leukemia (RNA-Seq of LMNA KD) 7.83
The Unfolded Protein Response Regulator, ATF6, Promotes Mesodermal Differentiation 7.72
Ribosomal footprinting of MDA_Ctrl and MDA_Arg overexpression cell lines 7.66
Quiescent glioblastoma cells shift to an epithelial-mesenchymal transition-like gene program 7.64
Pre-mRNA Splicing is Facilitated by an Optimal RNA Polymerase II Elongation Rate 7.58
Bromodomain-containing Protein 4 (BRD4) is Required for the Maintenance of a Mammary Epithelial Phenotype 7.56
Bromodomain-containing Protein 4 (BRD4) is Required for the Maintenance of a Mammary Epithelial Phenotype [RNA-Seq] 7.56
Cellular gene expression during Hepatitis C Virus replication revealed by Ribosome profiling 7.54
RNA-seq of synchronized S phase or G2 phase cells treated with an ATR inhibitor 7.54
PTEN suppresses neoplastic transformation of human neural stem cells by transcriptional repression of Pax7 7.51
RNA-Seq analysis RPE1 cells following exposure to Nutlin-3 to identify target genes of p53 [tpo12] 7.5
snRNAs as regulators of alternative splicing 7.4
Divergent effects of eRF3 and Upf1 on the expression of uORF carrying mRNAs and ribosome protein genes 7.4
Next Generation Sequencing Facilitates Quantitative Analysis of transcriptomes of human cord blood CD34+ cells treated with HDAC5 inhibitor 7.35
Human serum and heparin-free platelet lysate as appropriate xeno-free alternatives for production of human MuStem cell batches 7.34
Developmental stage specific chromosome architecture in human erythroid cells 7.3
Developmental stage specific chromosome architecture in human erythroid cells (RNA-seq) 7.3
LIN28A Over-expression RNAseq 7.28
Distinct gene expression profile of Huh7 cell lines stably overexpressing CRABP1 or 2 7.27
CHD1 loss sensitizes prostate cancer to DNA damaging therapy by promoting error-prone double-strand break repair 7.24
Pervasive transcription read-through promotes aberrant expression of oncogenes and RNA chimeras in renal carcinoma 7.23
N6-methyladenosine mRNA marking promotes selective translation of regulons required for human erythropoiesis [RNA-Seq] 7.22
The RNA exosome nuclease complex regulates human embryonic stem cell differentiation [RNA-Seq rescue_SS] 7.2
Differentially expressed vascular development genes for iPSC-ECs from CDI 7.19
The E3 ubiquitin ligase HectD1 suppresses EMT and metastasis by targeting the +TIP protein ACF7 for degradation 7.19
Mitochondrial dsRNA triggers antiviral signalling in humans 7.14
Dioxin and AHR impairs mesoderm gene expression and cardiac differentiation in human embryonic stem cells (RNA-Seq) 7.03
Dioxin and AHR impairs mesoderm gene expression and cardiac differentiation in human embryonic stem cells 7.03
Nucleotide stress induction of HEXIM1 suppresses melanoma by modulating cancer cell-specific gene transcription 6.96
The SPOP-containing Complex Functions as an E3 Ligase for SETD2 to Regulate Gene-Specific H3K36me3-Coupled Alternative Splicing 6.95
Role for citron kinase in prostate cancer growth 6.91
Bromodomain inhibition of the transcriptional coactivators CBP/EP300 as a therapeutic strategy to target the IRF4 network in multiple myeloma 6.9
Bromodomain inhibition of the transcriptional coactivators CBP/EP300 as a therapeutic strategy to target the IRF4 network in multiple myeloma (RNA-Seq) 6.9
Gene expression changes after LOC550643 silencing 6.83
An RNA-centric dissection of host complexes controlling flavivirus infection [RNA-Seq] 6.83
An RNA-centric dissection of host complexes controlling flavivirus infection 6.83
A potent and selective small-molecule degrader of STAT3 achieves complete tumor regression in vivo 6.81
Global analysis of enhancer targets: Mosaic-seq 6.8
The hepatitis C viral protein NS5A stabilizes growth-regulatory human transcripts 6.79
Altering cancer transcriptomes using epigenomic inhibitors [RNA-Seq] 6.78
Altering cancer transcriptomes using epigenomic inhibitors 6.78
RUNX1-ETO and RUNX1-EVI-1 differentially program the chromatin landscape in t(3;21) and t(8;21) AML but share global C/EBP-alpha dysfunction 6.77
RUNX1-ETO and RUNX1-EVI-1 differentially program the chromatin landscape in t(3;21) and t(8;21) AML but share global C/EBP-alpha dysfunction (RNA-Seq) 6.77
Ex-vivo Human Hematopoietic Stem Cell Expansion Requires Coordination of Cellular Reprogramming with Mitochondrial Remodeling and P53 Activation [bulk] 6.76
Gata6 potently initiates reprogramming of pluripotent and differentiated cells to extraembryonic endoderm stem cells 6.75
Gata6 potently initiates reprogramming of pluripotent and differentiated cells to extraembryonic endoderm stem cells [ChIP-Seq & RNA-Seq] 6.75
Comparison of expression profiles of APP-depleted prostate cancer cells (LNCaP) 6.73
RNAseq of PRMT4KD in human cord blood derived CD34+ cells 6.71
Effect of REST on cancer invasiveness in MCF-7 and MDA-MB-231 cells using RNA-sequencing (RNA-seq) analysis . 6.69
An improved method for circular RNA purification that efficiently removes linear RNAs containing G-quadruplexes or structured 3’ ends 6.67
Lipid catabolism inhibition sensitizes prostate cancer cells to antiandrogen blockade 6.65
Unique features and clinical importance of acute alloreactive immune responses 6.65
CROP-Seq in Primary Human T Cells 6.64
ETV7 and interferon response 6.62
Impact of ETV7 activity on interferon-stimulated gene expression in 293T cells treated with interferon alpha 6.62
Base-resolution mapping reveals distinct classes of N1-methyladenosine methylome in nuclear- and mitochondrial-encoded transcripts 6.61
MKL1 augments megakaryocyte maturation by enhancing the SRF regulatory axis 6.6
MKL1 augments megakaryocyte maturation by enhancing the SRF regulatory axis [RNA-seq] 6.6
Integrating single-cell transcriptomic data across different conditions, technologies, and species 6.59
mRNA expression profile of Lymphocytes 6.56
Gene expression analysis of CD4+ and CD4- ILC1 subsets by RNAseq 6.55
Single-cell analysis of adult human ovary using 10X genomics 6.54
Genome-wide discovery of human splicing branchpoints [RNAse] 6.52
Proteinase-Activated Receptor 4 (PAR4) mediates cell membrane blebbing in a Gaq/11, Gai independent, RhoA and ß-arrestin-dependent manner. 6.51
Global transcriptional profiling changes upon knockdown of LKB1 in human glioblastoma cell lines 6.5
Activation of PARP-1 by snoRNAs Controls Ribosome Biogenesis and Cell Growth via the RNA Helicase DDX21 6.49
Activation of PARP-1 by snoRNAs Controls Ribosome Biogenesis and Cell Growth via the RNA Helicase DDX21 (RNA-Seq) 6.49
TMED9-gated CNIH4 and TGFa signaling promotes pro-metastatic states in human primary colon cancer cells 6.49
Enriched retinal ganglion cells derived from human embryonic stem cells (RNA-seq) 6.47
A non-catalytic function of carbonic anhydrase IX contributes to the glycolytic phenotype and pH regulation in human breast cancer cells 6.46
MYC dependent mRNA translation shapes gene expression and cell biology 6.46
miR-450a acts as a tumor suppressor in ovarian cancer by readjusting energy metabolism 6.44
Impact of DNA MMR activity on antiviral gene expression in H441 cells infected with influenza A virus 6.44
High resolution ChIP sequencing reveals novel bindings targets and prognostic role for SOX11 in Mantle cell lymphoma 6.41
High resolution ChIP sequencing reveals novel bindings targets and prognostic role for SOX11 in Mantle cell lymphoma (RNA-Seq) 6.41
Triplet nucleotide repeat-based siRNAs are highly toxic to cancer cells 6.39
PHF20 readers link methylation of histone H3K4 and p53 with H4K16 acetylation 6.36
The RNA helicase DDX6 regulates self-renewal and differentiation of human and mouse stem cells [RNA-Seq] 6.35
Differential roles of human PUS10 in miRNA processing and tRNA pseudouridylation 6.35
Transcriptome profiling identified a 3-lncRNA regulatory network in transthyretin against glucose induced hRECs dysfunction 6.33
Genome wide expression change by RNF168 knocking down in NEC cells 6.29
HEK293 TFAM Knockout Expression Study 6.27
Luminal lncRNAs Regulation by ERα-controlled Enhancers in a Ligand-independent Manner in Breast Cancer Cells 6.26
Safeguarding nucleolar homeostasis by CBX4 alleviates senescence and osteoarthritis 6.23
Enhancement of Human B Cell Differentiation and Function in Lymph Nodes by the TLR9 Agonist MGN1703 6.22
Gene-Edited Human Kidney Organoids Reveal Mechanisms of Disease in Podocyte Development 6.21
The Genetic Landscape of Diamond-Blackfan Anemia 6.21
miRNA-1343 attenuates pathways of fibrosis by targeting the TGF-beta receptors [RNA-seq] 6.2
Nucleotide excision repair capacity increases during differentiation of human embryonic carcinoma cells into neurons and muscle cells 6.19
Characterizing the contrasting roles of JMJD3 and UTX histone demethylases in T cell acute lymphoblastic leukemia [short_hairpins_RNA-seq] 6.17
The MLL-AF9 and MLL-AF4 oncofusion proteins bind a distinct enhancer repertoire and target the RUNX1 program in MLLr AML 6.15
Expression data from A2780 cells treated with DMSO, Olaparib(Ola), Palbociclib(PD), and their combination (Ola/PD) 6.15
RNA expression profiling of human mPB or CB-derived CD34+ cells treated with UM171 at different doses 6.14
Next Generation Sequencing Facilitates Quantitative Analysis of HIV-1 Latency in Central Memory T Cells 6.14
Alu RNA modulates the expression of cell cycle genes in human fibroblasts 6.12
Cell differentiation grade determines distinct FOXA2 contributions to the cis-regulatory networks of pancreatic cancer cells [RNA-seq] 6.1
Cell differentiation grade determines distinct FOXA2 contributions to the cis-regulatory networks of pancreatic cancer cells 6.1
High-efficiency RNA-based reprogramming of human primary fibroblasts 6.09
Transcriptomic analysis of effect of oncolytic measles virus (MV) on transformed and non-transformed bone marrow-derived mesenchymal stem cells (MSCs) 6.09
Genome-wide CRISPR-Cas9 screen identifies druggable synthetic lethality between LSD1 and MTORC1 in MLL-translocated AML 6.08
Identification of HOXB13 target genes responsive to BET inhibitors 6.05
Adaptive chromatin remodeling in glioblastoma stem cell plasticity and drug tolerance 6.02
N6-methyladenosine mRNA marking promotes selective translation of regulons required for human erythropoiesis[Ribosome Profiling] 6.0
The mechanism of HHT in treating acute myeloid leukemia on RNA level. 5.99
Cerebellar differentiation in Ataxia-Telangiectasia 5.97
HuR controls apoptosis and activation response without effects on cytokine 3′ UTRs 5.96
The effects of chemokines CCL2/7 on MDA-MB-231-FOXC1 cells 5.94
RNA-seq Profiles in Transcription elongation factors are in vivo-specific cancer dependencies in glioma 5.92
Transcription elongation factors are in vivo-specific cancer dependencies in glioma 5.92
RNA-seq analysis of RALD iPSCs after in vitro differentiation 5.91
R430: A potent inbibitor of DNA and RNA viruses 5.91
Selectively targeting bromodomain and extraterminal proteins for degradation as a novel anti-glioblastoma strategy [RNA-seq] 5.91
LncRNA expression profiling of ischemic stroke patients 5.91
Retinoic Acid Induced Transcriptional Repressor HIC1 is Required for Suppressive Function of Human Induced Regulatory T cells [RNA-Seq 1] 5.89
High-resolution liver cancer genomic profiling links etiology, epigenetic and mutation signatures [RNA-Seq] 5.89
High-resolution liver cancer genomic profiling links etiology, epigenetic and mutation signatures 5.89
Genome-wide analysis of ferroptosis related genes in liver cancer cells. 5.86
RNAseq of ribosomal fractionation to assess the effect of CBFB on translation regulation 5.85
Parkinson’s Disease Genetic Risk in a Midbrain Neuronal Cell Line 5.76
Landscape and variation of RNA secondary structure across the human transcriptome 5.76
Integrin signaling regulates YAP/TAZ to control skin homeostasis 5.74
RNA-sequencing of human vascular endothelial cells after si-RNA mediated gene silencing of interleukin-6 (IL6) 5.73
Total RNA-seq in ALL-SIL upon TLX1 knockdown 5.7
The LINC01138 Drives Malignancies via Activating Arginine Methyltransferase 5 in Hepatocellular Carcinoma 5.7
Culture-induced recurrent epigenetic aberrations in human pluripotent stem cells 5.68
Culture-induced recurrent epigenetic aberrations in human pluripotent stem cells [RNA-seq] 5.68
Functional characterization of RNA-binding protein IMP2 in primary Glioma cell lines [HTS] 5.62
Functional characterization of RNA-binding protein IMP2 in primary Glioma cell lines 5.62
β-catenin/Tcf7l2 dependent transcriptional regulation of GLUT1 gene expression by Zic family proteins in colon cancer 5.55
MUC1-C represses the RASSF1A tumor suppressor and activated Kras signaling in human carcinoma cells 5.52
Differential gene expression tools exhibit substandard performance for long non-coding RNA-sequencing data 5.52
Integrative analysis identifies lincRNAs up- and downstream of neuroblastoma driver genes (ALK) 5.52
ATXN7L3 And ENY2 Coordinate Activity Of Multiple H2B Deubiquitinases Important For Cellular Proliferation And Tumor Growth 5.51
ATXN7L3 And ENY2 Coordinate Activity Of Multiple H2B Deubiquitinases Important For Cellular Proliferation And Tumor Growth [RNA-Seq] 5.51
Rorc disruption in human FG pancreatic cancer cells 5.48
mitoCPR - a surveillance pathway that protects mitochondria in response to mitochondrial import stress 5.46
mitoCPR - a surveillance pathway that protects mitochondria in response to mitochondrial import stress [human] 5.46
Mining the stiffness-sensitive transcriptome in human vascular smooth muscle cells identifies long non-coding RNA stiffness regulators 5.46
5.46
Generating Patterned Kidney Organoids for Studying Development and Diseases 5.45
Epigenetic Therapy Increases Therapeutic Efficacy in Myeloproliferative Neoplasms Through Inhibition of Aberrant Inflammatory Signaling 5.45
Transcriptome landscape of HeLa response upon triamcinolone acetonide 5.42
Effect of ER stress on MUC1 kidney disease patient derived cells and and treatment by BRD4780 5.41
The long non-coding RNA MALAT1 contributes to the pathogenesis of multiple sclerosis through alternative splicing and backsplicing regulation 5.4
Targeting HuH7 cells with JumonjiC Lysine Demethylase Inhibitors (RNA-Seq) 5.38
A novel CRISPR-engineered prostate cancer cell line defines the AR-V transcriptome and identifies PARP inhibitor sensitivities. 5.36
An atlas of TNF-α-responsive promoters and enhancers in the intestinal epithelial cell model Caco-2 5.36
RNA transcriptome sequencing analysis of SGC-7901 cells transfected with tcons_00001221 shRNA or control shRNA 5.34
Genome models integrating chromatin contacts and nuclear lamin-genome interactions reveal implications of laminopathy-causing lamin mutations on genome architecture 5.33
Nascent RNA Sequencing after NMYC activation in SH-EP MYCNER cells 5.29
Single-cell transcription profiling in KS1 patient iPSCs and NPCs 5.25
Expanding the Nucleoside Recoding Toolkit: Revealing RNA Population Dynamics with 6-thioguanisine 5.23
Expression analysis of genes modulated after knock-down of lncRNA CHROME. 5.22
Human Adult Sorted Live Cell Erythroblasts transduced with Sigma shRNA Clone TRCN0000005418 targeting RIOK3 with puromycin selection RNAseq 5.19
Dynamics of the human and viral m6A RNA methylomes during HIV-1 infection of T cells 5.17
Deciphering the ‘m6A code’ via quantitative profiling of m6A at single-nucleotide resolution [III] 5.14
Deciphering the ‘m6A code’ via quantitative profiling of m6A at single-nucleotide resolution 5.14
Genome-wide discovery of human splicing branchpoints 5.14
Characterisation of HIF-dependent alternative isoforms in pancreatic cancer 5.05
Enhancement of Arterial Specification in Human Pluripotent Stem Cell Cultures Promotes Definitive Hematoendothelial Program with Broad Myelolymphoid Potential 4.93
Analysis of HPV16 E2 host gene expression using TERT immortalized keratinocytes (NOKs) cell lines and RNA-sequencing 4.92
Quantitative Analysis of p53 and/or TGFBR2 Knockdown Endothelial Transcriptomes after Irradiation 4.9
Transcriptomic insights into human decidual and peripheral blood CD8 T cells 4.88
Comprehensive comparative analysis of RNA sequencing methods for degraded or low input samples 4.88
Translating transcriptome of cancer cells in situ in mesenchymal-rich tumor microenvironment 4.87
Stem cell and neurogenic gene-expression profiles link prostate basal cells to aggressive prostate cancer 4.8
Translocation of dense granule effectors across the parasitophorous vacuole membrane in Toxoplasma-infected cells requires the activity of ROP17, a rhoptry protein kinase 4.78
SPOP mutation confers intrinsic BET inhibitor resistance in prostate cancer 4.78
The immediate impact of exoribonucleolysis on nuclear RNA processing, turnover and transcriptional control revealed by rapid depletion of DIS3, EXOSC10 or XRN2 from human cells 4.74
PAX3-FOXO1 requires BRD4 to drive oncogene addiction in RMS cells [RNA-seq] 4.74
Epigenetic Lanscape and BRD4 Transcriptional Dependency of PAX3-FOXO1 Driven Rhabdomyosarcoma 4.74
Single-cell RNA sequencing-based CRISPRi screening resolves molecular drivers of early human endoderm development 4.74
Poly(A)-specific ribonuclease (PARN) mediates 3' end maturation of the telomerase RNA component 4.72
Gene expression profiling by RNA-seq in hTert-HME1 cell line treated with control or BRCA2 siRNAs and grown with or without EGF (epithelial growth factor) 4.67
Innate-like activation of mucosal-associated invariant T cells in mycobacterial infection 4.56
Image based identification and targeting of cancer stem cells in pancreatic adenocarcinoma (PDAC) 4.52
Neurotrophic Tyrosine Kinase Receptor 1 is Epigenetically Regulated by IL-13 and Contributes to Allergic Inflammation 4.52
Perivascular signals alter global genomic profile of glioblastoma and response to temozolomide in a gelatin hydrogel 4.49
LEDGF and HDGF2, histone H3K36 methyl-binding proteins that assist RNA polymerase II transcription through nucleosomes 4.48
The metabolome regulates the epigenetic landscape during naïve to primed human embryonic stem cell transition 4.39
RNA-Seq analysis of Head and Neck Squamous cell carcinoma cell-lines 4.35
The DPYSL2 gene connects mTOR and schizophrenia 4.34
Cooperation of GRSF1 and the mitochondrial degradosome (hSuv3-PNPase complex) in degradation of mitochondrial RNA 4.31
Mitotically associated long non-coding RNA, MANCR regulates cell cycle in triple negative breast cancer cells  4.24
ATRX is necessary for cellular senescence and represses HRAS to drive cells from quiescence into senescence 4.23
ATRX is necessary for cellular senescence and represses HRAS to drive cells from quiescence into senescence [RNA-Seq] 4.23
RNA-Seq of polysome profiling fractions and whole cell lysates of UVB-irradiated N-TERT keratinocytes 4.17
Gene expression profiles in NORAD knockout and PUMILIO overexpressing cells 4.14
THZ1 targeting CDK7 suppresses STAT transcriptional activity and sensitizes T-cell lymphomas to BCL2 inhibitors 4.14
Induction of human regulatory innate lymphoid cells from group 2 innate lymphoid cells by retinoic acid 4.13
Role of BET proteins in YAP/TAZ-dependent transcription [RNA-seq 2] 4.1
Binding to SMN2 pre-mRNA-Protein complex elicits specificity for small molecule splicing modifiers 4.07
HOXC6 affects the malignant phenotype of esophageal squamous cell carcinoma cells 4.06
Profiling of protrusion-enriched RNAs from human breast cancer cell line MDA-MB-231 4.06
A Surveillance System of Active Enhancers by a RACK7-histone Demethylase Complex (RNA-Seq I) 4.05
JQ1 +/- Vemurafenib in BRAF mutant melanoma (A375) 4.0
B-cell activating factor (BAFF) stimulation of Burkitt Lymphoma cell line 4.0
B-cell activating factor (BAFF) stimulation of Burkitt Lymphoma cell line [RNA-Seq] 4.0
Probing the Global Cellular Responses to Lipotoxicity Caused by Saturated Fatty Acids 3.96
Effect of PDZ domain binding Kinase inhibition using TOPK-32 (called PBKi) on C4-2 cell transcriptome 3.94
Single-cell Map of Diverse Immune Phenotypes in the Breast Tumor Microenvironment - 5' RNA sequencing and TCR sequencing 3.88
mRNA sequencing identifies differential gene expresssion profiles between ASCC3 knock-down cells and control cells 3.87
PRMT5 Interacts with the BCL6 Oncoprotein and is Required for Germinal Center Formation and Lymphoma Cell Survival 3.86
Abnormal RNA splicing and genomic instability after induction of DNMT3A mutations by CRISPR/Cas9 gene editing [RNA-Seq] 3.82
Abnormal RNA splicing and genomic instability after induction of DNMT3A mutations by CRISPR/Cas9 gene editing 3.82
RNA deep sequencing analysis of glioma stem cells(GSCs) and non-GSCs 3.79
DHX15 regulates CMTR1-dependent gene expression and cell proliferation 3.75
Tracking transcriptional changes in a species-specific manner during experimental hepatoblastoma progression in vivo 3.73
Human cells contain natural double-stranded RNAs with potential regulatory capacity 3.69
RNA-seq analysis of human cardiosphere cells with different tubule supportive potential 3.69
β-Caryophyllene Enhances the Transcriptional Upregulation of SREBP-dependent Lipid Biosynthesis in Breast Cancer Cells 3.67
K562 polyA RNA-Seq 3.67
mRNA differential expression in LNCaP cells expressing the wild-type androgen receptor (AR-WT) or the ligand-independent AR-V7 splice variant 3.66
Differential expression in LNCaP cells expressing the wild-type androgen receptor (AR-WT) or the ligand-independent AR-V7 splice variant 3.66
Folliculin regulates mTORC1/2 and WNT pathways in early human pluripotency 3.6
Selective expression of long non-coding RNAs in a breast cancer cell progression model 3.51
Evidence for rRNA 2'-O-methylation plasticity: control of intrinsic translational capabilities of human ribosomes 3.5
Profiling of lung tumor-infiltrating CD8 T cells according to their expression status of CD39 3.5
Role of BET proteins in YAP/TAZ-dependent transcription [RNA-seq 1] 3.5
Chromatin remodeling mediated by ARID1A is indispensable for normal hematopoiesis in mice (human RNA-Seq) 3.49
TAF1 is critical for AE driven leukemogenesis 3.45
TAF1 is critical for AE driven leukemogenesis [RNA-seq] 3.45
Ribosome profiling upon inhibition of eIF4A 3.43
Knock-down of Ror1 in MDA-MB-231 cell line decreases cell invasiveness 3.42
The NORAD lncRNA assembles a topoisomerase complex critical for genome stability [RNA-seq] 3.41
The NORAD lncRNA assembles a topoisomerase complex critical for genome stability 3.41
RNA-sequencing of the GSI treatment of the CUTLL1 cell line 3.39
Truncation of LOC100288798 (SLC38A4-AS) lncRNA in human haploid KBM7 cell line 3.32
RNA sequencing of mechanically strained NHEKs and control NHEKs 3.28
Controlling for gene expression changes in transcription factor protein networks. 3.28
FBP2 inhibits sarcoma progression by restraining mitochondrial biogenesis 3.17
NF-κB p65 dimerization and DNA-binding is important for inflammatory gene expression 3.17
Perlman syndrome nuclease DIS3L2 controls cytoplasmic non-coding RNAs and provides surveillance pathway for maturing snRNAs 3.14
Identification of a unique subtype of lung squamous cell carcinoma defined by SOX2 and a neural differentiation factor BRN2 [RNA-seq] 3.12
Identification of a unique subtype of lung squamous cell carcinoma defined by SOX2 and a neural differentiation factor BRN2 3.12
Luminal subtype-specific circRNAs in breast cancer cells by a novel tool for external data analysis. 3.09
RNA-seq analysis of A2780 and OVCAR3 human ovarian cancer cell lines after overexpression of collagen type XI alpha 1 (COL11A1) 3.07
Real-time observation of light-controlled transcription in living cells 3.07
Antioxidant metabolism in activated CD8+ T cells regulates stem-like human memory T cell formation and anti-tumor immunity 3.06
KSRP specifies monocytic and granulocytic differentiation through regulating miR-129 biogenesis and RUNX1 expression 3.05
Precise Gene Editing Preserves Hematopoietic Stem Cell Function Following Transient p53-Mediate DNA Damage Response [bulk RNA-seq] 2.99
Derivation of kidney organoids from human pluripotent stem cells [RNA-Seq: Data Set 2] 2.89
Tumor- and cytokine-primed human natural killer cells exhibit distinct phenotypic and transcriptional signatures [RNA-seq] 2.89
Tumor- and cytokine-primed human natural killer cells exhibit distinct phenotypic and transcriptional signatures 2.89
Trisomy of a ‘Down syndrome critical region’ globally amplifies transcription via HMGN1 overexpression [NALM6 RNA-Seq] 2.86
B cells expressing the IgA receptor FcRL4 participate in the autoimmune response in patients with rheumatoid arthritis 2.84
Identifying markers predicting successful graft outcome for clinical translation of hESC-based cell therapy for Parkinson’s disease 2.8
Role of FGFR1 in neuronal devlopment 2.77
Integrated single cell analysis of blood and cerebrospinal fluid leukocytes in multiple sclerosis 2.77
Functional significance of the HIV-1 Tat signature amino acid residues 2.77
Epigenetic reprogramming of melanoma cells by vitamin C treatment 2.73
DNMT and HDAC inhibitors globally induce cryptic TSSs encoded in long terminal repeats 2.68
RNA-seq profile of expanded human ST2-transduced Tregs cultured with IL-2 and TCR in the presence or absence of IL-33 2.63
MAIT cell RNA sequencing 2.59
Activation of the p53 transcriptional program sensitizes cancer cells to Cdk7 inhibitors 2.59
Ro60-knockout cells 2.53
Single-cell analysis of human kidney organoids 2.53
Tissue-resident memory T cells mediate immune homeostasis in the human pancreas through the PD-1/PD-L1 pathway 2.52
Transcriptome analysis upon C6orf203 silencing 2.49
Inheritable Silencing of Endogenous Genes by Hit-and-Run Targeted Epigenetic Editing 2.47
Single-cell RNA-seq reveals differentiation of bona fide human pDCs and cDC1s in cultures of cord blood CD34+ progenitors, and a newly identified terminal differentiation step of cDC1s 2.47
Engineered Nanointerfaces for Microfluidic Isolation and Molecular Profiling of Tumor-specific Extracellular Vesicles 2.44
Gene expression profiling by RNA-seq of SW480 TGM2 knockdown cells 2.42
Genome-wide Dose-dependent Inhibition of Histone Deacetylases Reveals Their Roles in Enhancer Remodeling and Suppression of Oncogenic Super-enhancers 2.41
Primary Human B-cell Temporal Response to CD40L Stimulation 2.4
A Reproducibility-Based Computational Framework Identifies An Inducible, Enhanced Antiviral Dendritic Cell State In HIV-1 Elite Controllers (TLR perturbation Bulk RNA-Seq) 2.35
Single-Cell reconstruction of differentiation trajectory reveals essential dynamics in human cardiac lineage commitment 2.35
Time series single-cell transcriptomic analysis of AEC2 directed differentiation 2.34
SQSTM1/p62-directed metabolic reprogramming is essential for normal neurodifferentiation 2.31
Evolving Spindlin1 Small Molecule Inhibitors Using Protein Microarrays 2.29
HMGA2 Promotes Long-Term Engraftment and Myelo-Erythroid Differentiation of Human Hematopoietic Stem and Progenitor Cells 2.29
Genomic profiling of human spermatogonial stem cells [BulkRNA-Seq] 2.28
RNA-sequencing of cells derived from the site of inflammation of Juvenile Idiopathic Arthritis patients 2.23
Epigenetic profiling and RNA-sequencing of Juvenile Idiopathic Arthritits (JIA) patients 2.23
Homolog-selective degradation as a strategy to probe the function of CDK6 in AML 2.21
An Argonaute phosphorylation cycle promotes microRNA-mediated silencing [whole transcriptome RNA-seq] 2.19
An evolutionary recent IFN-IL-6-CEBP axis is linked to monocyte expansion and tuberculosis severity in humans. 2.16
Mitochondrial unfolded protein response controls matrix pre-RNA processing and translation 2.16
RNA deep sequencing to compare genome-wide differences between PRMT5/knockdown and control AML cells 2.15
Direct identification of endogenous SMG6 targets and a preferred motif spanning SMG6 cleavage sites by parallel analysis of RNA ends in human cells 1.95
Time series total RNA sequencing of a differentiation of human embryonic stem cells towards trophoblast lineage 1.92
Circular RNA profiling reveals the different distribution/characteristic and possible transport mechanism among the subcellular fractions 1.87
Domain-focused CRISPR-screen identifies HRI as a fetal hemoglobin regulator in human erythroid cells 1.84
Effect of BB608 on Gene Expression in HNSCC Cell Line 1.82
Molecular characterization of BRSK2 and BRSK1 kinases as negative regulators of the NRF2 transcription factor 1.69
RNA-seq analysis of PRMT5-regulated genes in irradiated/non-irradiated LNCaP cells 1.66
Xrn2 accelerates termination by RNA polymerase II, which is underpinned by CPSF73 activity 1.63
The human cellular nucleic acid binding protien binds G-rich elements close to translation initiation sires and promotes translation. [RNA-Seq] 1.62
The human cellular nucleic acid binding protien binds G-rich elements close to translation initiation sires and promotes translation. 1.62
The novel lncRNA lnc-NR2F1 is pro-neurogenic and mutated in human neurodevelopmental disorders 1.6
The novel lncRNA lnc-NR2F1 is pro-neurogenic and mutated in human neurodevelopmental disorders [lnc-Nr2f1 overexpression] 1.6
PolyA+ RNA-seq in ALL-SIL upon TLX1 knockdown 1.57
ARID1A is a critical regulator of luminal identity and therapeutic response in oestrogen receptor-positive breast cancer (RNA-Seq) 1.57
Nucleotide stress induction of HEXIM1 suppresses melanoma by modulating cancer cell-specific gene transcription [RNA-Seq1] 1.55
RNA:DNA hybrids in the human genome have distinctive nucleotide characteristics, chromatin composition, and transcriptional relationships 1.54
RNA:DNA hybrids in the human genome have distinctive nucleotide characteristics, chromatin composition, and transcriptional relationships (RNA-seq) 1.54
RNA-Seq data of NCI-H82 cells expressing a Dox-On pRB (pTripZ RB1) grown in the presence or absence of DOX and then treated with vehicle or AZD2811. 1.53
RNA G-quadruplexes mark repressive upstream open reading frames in human mRNAs 1.52
Effect of venetoclax, tedizolid, and combination treatment on gene expression in a venetoclax-resistant AML cell line 1.48
CRISPR Display: A modular method for locus-specific targeting of long noncoding RNAs and synthetic RNA devices in vivo 1.48
CRISPR Display: A modular method for locus-specific targeting of long noncoding RNAs and synthetic RNA devices in vivo [RNA-Seq] 1.48
Interactome (iCLIP) and Translatome ( Polysome profiling) of Musashi 2 (MSI2) targets in K562 1.47
Coronary Artery Disease Associated Transcription Factor TCF21 Regulates Smooth Muscle Precursor Cells that Contribute to the Fibrous Cap 1.45
RNA sequencing from FOXM1 knockout HEK293T cells reconstituted with FOXM1 isoforms a, b and c. 1.38
SMAD2/3 are redirected to novel sites in MCF10A MII after prolonged TGFβ stimulation 1.37
JUNB is a critical AP1 component for SMAD2/3 binding after TGFβ stimulation [RNA-seq] 1.37
Gene expression profiling of neural crest progenitor cultures derived from human embryonic stem cells carrying nonsense mutations in the Polycomb gene ASXL1 1.33
Identification of microRNA-668 and microRNA-489 targets by RISC immunoprecipitation 1.26
C19ORF66 broadly escapes viral-induced endonuclease cleavage and restricts Kaposi’s Sarcoma Associated Herpesvirus (KSHV) 1.24
RNA-seq analysis reveals profound changes in transcript profiles between siCon- and siH19-transfected uterine smooth muscle cells (USMC) 1.2
Genome Wide Chromatin Mapping of accessibility (ATAC-seq) and H3K27ac histone modifications in CD56bright and CD56dim natural killer cells 1.16
Clinical and genomic crosstalk between glucocorticoid receptor and estrogen receptor α in endometrial cancer 1.15
Clinical and genomic crosstalk between glucocorticoid receptor and estrogen receptor α in endometrial cancer [RNA-seq] 1.15
Single-cell RNAseq analysis of the empty and i8TF cell lines after 3 days of BL-CFC culture 1.14
Single cell transcriptomics reveals new insights on the dynamical function of transcription factors during blood stem and progenitor cell formation 1.14
Differential gene expression profiles in imatinib-resistant cell lines 1.08
Human Adult Sorted Live Cell Erythroblasts transduced with Sigma non-targeting shRNA negative control (SHC002V) with puromycin selection RNAseq 1.07
RNA-seq of ASXL2 shRNA KD in SKNO-1 cells 0.99
High-resolution comparative analysis of great ape genomes 0.94
CDK12 mediated transcriptional regulation in U2OS cells 0.93
Effects of Inhibition of CDK8/19 Mediator Kinase by Senexin B in HEK293 cells treated with or without TNF-alpha 0.92
Human Treg IL-12 stimulation 0.91
RNA sequencing with KSHV infection and enrichment for circular RNAs 0.87
Human Cord Blood Sorted Live Cell Erythroblasts RNA-Seq 0.83
DNMT1-associated long non-coding RNA regulate global gene expression and DNA methylation in colon cancer 0.81
HSB-2 cells stably expressing LDB1 or mutant LDB1 proteins 0.81
An siRNA screen identifies CHD4 as a target for epigenetic therapy 0.77
Genome-wide effect of inhibition of glutamine transporter ASCT2 in PC-3 cells by BenSer or GPNA 0.77
RNA-Seq of SHEP TET21N cells upon Doxorubicin treatment 0.77
Trisomy of a ‘Down syndrome critical region’ globally amplifies transcription via HMGN1 overexpression [SLAM-Seq] 0.75
Genome-wide mapping of DROSHA cleavage sites on primary microRNAs and novel substrates [RNA-seq] 0.75
Genome-wide mapping of DROSHA cleavage sites on primary microRNAs and novel substrates 0.75
Multiplexed engineering and analysis of endogenous enhancer activity in single cells: Mosaic-Seq of beta-globin locus (pooled infection) 0.72
Medial Ganglionic Eminence and Cortical Organoids Model Human Brain Development and Interneuron Migration [RNA-seq2] 0.69
A novel compound that blocks HIV-1 replication inhibits the splicing regulatory function of SRSF10 0.64
Definition of Natural Killer cell heterogeneity in humans and mice by high-throughput single-cell RNA sequencing 0.62
Mechanism suppressing H3K9 trimethylation in pluripotent stem cells and its demise by polyQ-expanded huntingtin mutations 0.62
Mechanism suppressing H3K9 trimethylation in pluripotent stem cells and its demise by polyQ-expanded huntingtin mutations [RNA-seq] 0.62
The impact of oil spill to lung health – insights from an RNA-seq study of human airway epithelial cells 0.6
Determining mRNA half-lives on a transcriptome-wide scale 0.58
Compare of gene expression between p16INK4A positive and negative regions of colon cancer from five patients 0.54
O-glcnAc reprograms cellular energetics 0.54
TALEN-based knockout of mir-141 and mir-200c in SK-BR-3 cells 0.53
miRNAs affected by antagomiR-17 treatment 0.52
Hsa-miR-139-5p/HNRNPF axis modulates gene-transcripts balance in thyroid cancer cells 0.48
Functional Significance of U2AF1 S34F Mutation in Lung Adenocarcinomas 0.48
GATA2 promotes hematopoietic development and represses cardiac differentiation of human mesoderm 0.44
Remodeling of Ago2-mRNA interactions upon cellular stress reflects miRNA complementarity and correlates with altered translation rates 0.44
Remodeling of Ago2-mRNA interactions upon cellular stress reflects miRNA complementarity and correlates with altered translation rates (part 4) 0.44
Transcriptomic analysis of the effect of histone H4 K31R mutation in U2OS cells 0.43
O-GlcNAc transferase fine-tunes MYC-dependent transcription to promote cell cycle 0.43
O-GlcNAc transferase fine-tunes MYC-dependent transcription to promote cell cycle [RNA-seq] 0.43
Identification of trans regulators of ADAR and A-to-I RNA editing using RNA-seq 0.42
Unbiased identification of trans regulators of ADAR and A-to-I RNA editing 0.42
Genome-wide DNA hypomethylation and RNA:DNA hybrid accumulation in Aicardi-Goutières syndrome 0.35
p53 activity results in DNA replication fork processivity 0.34
Comparative Analysis of Cas9 Activators Across Multiple Species 0.33
Induced DNA demethylation, genome instability and transcription 0.27
Impact of DNA demethylation agents (5-azacytidine or vitamin C) on gene expression in glioblastoma HSR-GBM1 cells 0.27
RNA seq analysis of human Fetal and adult derived Enterospheres 0.25
Functional Inflammatory Profiles Distinguish Myelin-Reactive T Cells from Patients with Multiple Sclerosis 0.21
DLX3 alters transcriptomic profile of adhesion, cell cycle, and cell death in Squamous Cell Carcinoma Cells 0.15
DLX3-dependent p53 signaling network controls keratinocyte cell cycle and squamous tumor growth 0.15
Global transcriptome analysis of WT versus HEB-/- hESCs 0.11
Targets mediated microRNA arm-imbalance promotes gastric cancer progression [lncRNA] 0.11
Transcription factors and stress response gene alterations in human keratinocytes following Solar Simulated Ultra Violet Radiation 0.1
Functional genomic analysis of the haploinsufficient tumor suppressor, CUX1 0.06
siRNA-mediated knockdown 0.05
Targeting Spt5-Pol II small-molecule inhibitors uncouple distinct activities and reveal additional regulatory roles 0.01


Contact Us

For scientific and technical queries contact Butte Lab @UCSF


Cite GENEVA Tool

Manuscript in Preparation